Theriva Biologics (TOVX) logo

Theriva Biologics (TOVX) stock

Worth $7.1MShares as of Aug 7

$0.15
-7.00%

As of Tuesday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score TOVX. It is too small and priced too low for a fair Quality Score.

Healthcare · Biotech

Next2H 2026“VIRAGE2 is expected to complete enrollment during the second half of 2026…”Trial start · SEC filing · Aug 11
Cash$11.3M, about 3 quarters at the last year's spendingOn Jun 30 · the company says “into Q1 2027”

Follow TOVX's trial news. Pro members can get an alert when Theriva Biologics files news, and see its trials, share raises, and its CEO's filings.

Get an alert when TOVX files news on its trialSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,168 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

Cash$11.3M, about 3 quarters at the last year's spendingOn Jun 30 · the company says “into Q1 2027”

What's next for TOVX, and how long its cash lasts

Next step the company has named

2H 2026“VIRAGE2 is expected to complete enrollment during the second half of 2026, and initial pharmacodynamic and safety/tolerability data”Trial start · SEC filing · Aug 11

What it means: when a trial begins, or reaches the stage the company named.

A trial underway
SYN-004 Safety and Tolerability in Allo-HCT SubjectsPhase 1/2 · Active · 36 people · main data estimated Sep 30, 2029 · NCT04692181

For Pro members: 60 filings.

Cash runway Jun 30 balance sheet

About 3 quarters

$11.3M in cash and short-term investments, at its spending over the last year

What it means: how long the cash would last at the same pace, before any new money. The company's estimate is “into Q1 2027” (8-K, Aug 11).

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

No shelf registration or at-the-market program on file in the last three years.

For Pro members: 3 raises and their amounts, and the share count against a year ago.

Insiders

No open-market buys or sales by its officers or directors in their filings of the last year.

From Form 4: open-market buys and sales only.

For Pro members: every trade, and Steven Shallcross’s 2 filings and quotes.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

TOVX's latest filings

21 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why TOVX isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. TOVX is worth about $7.1M and trades at $0.15. A stock that clears every mark is scored from the next weekly rebuild.

Straight AnswersStraight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Every US stock, ranked live.

Insider and Congress trades, the chart, and the financials, in one score.

See every stock ranked

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

The price on this page is delayed at least 15 minutes.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.